Delayed pressure urticaria - Dapsone heading for first-line therapy?;Druckurtikaria - Dapson auf dem weg zur first-line-therapie?

JDDG - Journal of the German Society of Dermatology

Volumn 9, Issue 11, 2011, Pages 908-912

  Grundmann, Sonja Alexandra ^a   Kiefer, Sabine ^a   Luger, Thomas Anton ^a   Brehler, Randolf ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Chronic urticaria; Dapsone; Drug therapy; Pressure urticaria; Urticaria

Indexed keywords

ASCORBIC ACID; DAPSONE;

ADULT; ARTICLE; CHRONIC DISEASE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEALTH SURVEY; HEMOLYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; RETROSPECTIVE STUDY; SIDE EFFECT; TREATMENT FAILURE; URTICARIA;

EID: 84155167669     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/j.1610-0387.2011.07749.x     Document Type: Article

References (20)

1. Barlow RJ, Warburton F, Watson K, Black AK, Greaves MW. Diagnosis and incidence of delayed pressure urticaria in patients with chronic urticaria. J Am Acad Dermatol 1993;29:954-8. (Pubitemid 23360327)
2. Cassano N, Mastrandrea V, Vestita M, Vena GA. An overview of delayed pressure urticaria with special emphasis on pathogenesis and treatment. Dermatol Ther 2009;22 Suppl 1: S22-6.
3. Kobza-Black A. Delayed pressure urticaria. J Investig Dermatol Symp Proc 2001;6:148-9. (Pubitemid 33758592)
4. Fleischer M, Grabbe J. Physical urticaria. Hautarzt 2004;55:344-9. (Pubitemid 38661276)
5. Wedi B. Urticaria. J Dtsch Dermatol Ges 2008;6:306-17.
6. Wieczorek D, Raap U, Kapp A, Wedi B. Modern diagnosis and treatment of urticaria: five case reports. Hautarzt 2007;58:302-7. (Pubitemid 46623420)
7. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau A, Grattan CE, Kapp A, Merk H F, Rogala B, Saini S, Sanchez-Borges M, Schmid-Grendelmeier P, Schunemann H, Staubach P, Vena GA, Wedi B, Maurer M. EAACI/GA (2) LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009;64:1417-26.
8. Cassano N, Scoppio BM, Loviglio MC, Vena GA. Remission of delayed pressure urticaria after eradication of Blastocystis hominis. Acta Derm Venereol 2005;85:357-8. (Pubitemid 41113525)
9. Zuberbier T, Asero R, Bindslev-Jensen C, Walter Canonica G, Church MK, Gimenez-Arnau AM, Grattan CE, Kapp A, Maurer M, Merk HF, Rogala B, Saini S, Sanchez-Borges M, Schmid-Grendelmeier P, Schunemann H, Staubach P, Vena GA, Wedi B. EAACI/GA (2) LEN/EDF/WAO guideline: management of urticaria. Allergy 2009;64:1427-43.
10. Wedi B, Raap U, Wieczorek D, Kapp A. Urticaria and infections. Allergy Asthma Clin Immunol 2009;5:10.
11. Dover JS, Black AK, Ward AM, Greaves M W. Delayed pressure urticaria. Clinical features, laboratory investigations, and response to therapy of 44 patients. J Am Acad Dermatol 1988;18:1289-98.
12. Jauregui I, Ferrer M, Montoro J, Davila I, Bartra J, Del Cuvillo A, Mullol J, Sastre J, Valero A. Antihistamines in the treatment of chronic urticaria. J Investig Allergol Clin Immunol. 2007;17 Suppl 2:41-52. (Pubitemid 351252754)
13. Nettis E, Colanardi MC, Soccio AL, Ferrannini A, Vacca A. Desloratadine in combination with montelukast suppresses the dermographometer challenge test papule, and is effective in the treatment of delayed pressure urticaria: a randomized, double-blind, placebocontrolled study. Br J Dermatol 2006;155:1279-82. (Pubitemid 44730008)
14. Engin B, Ozdemir M. Prospective randomized non-blinded clinical trial on the use of dapsone plus antihistamine vs. antihistamine in patients with chronic idiopathic urticaria. J Eur Acad Dermatol Venereol 2008;22:481-6. (Pubitemid 351436921)
15. Wozel VE. Innovative use of dapsone. Dermatol Clin 28:599-610.
16. Dawn G, Urcelay M, Ah-Weng A, O'Neill SM, Douglas WS. Effect of high-dose intravenous immunoglobulin in delayed pressure urticaria. Br J Dermatol 2003;149:836-40. (Pubitemid 37412006)
17. Magerl M, Philipp S, Manasterski M, Friedrich M, Maurer M. Successful treatment of delayed pressure urticaria with anti-TNF-alpha. J Allergy Clin Immunol 2007;119:752-4.
18. Bindslev-Jensen C, Skov PS. Efficacy of omalizumab in delayed pressure urticaria: a case report. Allergy 2010;65:138-9.
19. Metz M, Altrichter S, Ardelean E, Kessler B, Krause K, Magerl M, Siebenhaar F, Weller K, Zuberbier T, Maurer M. Anti-immunoglobulin E treatment of patients with recalcitrant physical urticaria. Int Arch Allergy Immunol 2011;154:177-80.
20. Dunne J, Caron A, Menu P, Alayash AI, Buehler P W, Wilson MT, Silaghi-Dumitrescu R, Faivre B, Cooper CE. Ascorbate removes key precursors to oxidative damage by cell-free haemoglobin in vitro and in vivo. Biochem J 2006;399:513-24. (Pubitemid 44672642)